Skip to search formSkip to main contentSkip to account menu

prosigne

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Botulinum Toxin Type A

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effects of chronic treatment with botulinum toxin type A in salivary glands of rats: Histological and immunohistochemical analyses.
BACKGROUND The intraglandular application of botulinum neurotoxin type A (BoNT-A) is used in patients with neuromotor disorders… 
2018
2018
Six-Month Comparative Analysis Monitoring the Progression of the Largest Diameter of the Sweating Inhibition Halo of Different Botulinum Toxins Type-A.
Background Excessive sweating is a clinical condition that can be improved with type-A botulinum toxin (BTX-A). Objectives To… 
Review
2016
Review
2016
A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia
AbstractA systematic pair-wise comparison of all available botulinum toxin serotype A and B treatments for cervical dystonia (CD… 
2016
2016
Multicenter, prospective, comparative, randomized, double-blind clinical study comparing two botulinum toxin type A formulations registered in Brazil for the treatment of glabellar wrinkles
Introduction: Although there are differences arising from diverse formulations, botulinum toxin type A is widely marketed in… 
2014
2014
Comparison of Botox ® or Prosigne ® and Facial Nerve Blockade as Adjuvant in Chronic Migraine
Background: The treatments suggested for chronic migraine (CM) include: 1) intramuscular (im) botulinum toxin (BTX) every 12… 
2013
2013
A Double-Blind, Randomised, Crossover Trial of Two Botulinum Toxin Type A in Patients with Spasticity
Background Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new… 
2012
2012
Comparison of four botulinum neurotoxin type A preparations in the treatment of hyperdynamic forehead lines in men: a pilot study.
BACKGROUND Botulinum neurotoxin type A (BTXA) offers a minimally invasive approach for the treatment of facial rhytides and has… 
Review
2010
Review
2010
Prospective, Randomized, Double-Blind Study, Comparing Botulinum Toxins Type A Botox and Prosigne for Blepharospasm and Hemifacial Spasm Treatment
Botulinum toxin A (BTA) is considered an effective treatment of blepharospasm and hemifacial spasm, but there are few studies to… 
2010
2010
A Prospective, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Type A Botulinum Toxins Botox and Prosigne in the Treatment of Cervical Dystonia
Botulinum toxin A (BTA) is considered an effective treatment of cervical dystonia. The aim of this prospective, randomized… 
2010
2010
Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity.
PURPOSE To report our experience with the use of the botulinum toxin-A (BoNT/A) formulations Botox and Prosigne in the treatment… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)